A device for cooling therapy to reduce swelling after injuries
Ambulatory cryocooling therapy device
['FUNDING_SBIR_2'] · NANOHMICS, INC. · NIH-10932900
This study is testing a new hands-free cooling device that helps people recovering from injuries by reducing swelling and protecting their skin, making it easier for them to stay active while healing.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NANOHMICS, INC. (nih funded) |
| Locations | 1 site (AUSTIN, UNITED STATES) |
| Trial ID | NIH-10932900 on ClinicalTrials.gov |
What this research studies
This research investigates a new ambulatory cryocooling therapy device designed to provide long-term cold therapy for patients recovering from injuries. The device aims to deliver controlled cooling to the affected area, reducing swelling and preventing tissue damage while allowing patients to maintain mobility. Unlike traditional ice packs, this device can be worn hands-free and programmed for extended use, offering a more effective and safer alternative for managing inflammation. The approach combines periods of cooling with brief warming intervals to protect the skin from damage.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals recovering from injuries that cause swelling, such as sports injuries, post-surgical patients, or those with conditions like deep vein thrombosis.
Not a fit: Patients who do not experience swelling or inflammation from injuries may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve recovery outcomes for patients by providing effective and safe cold therapy.
How similar studies have performed: Previous studies have shown success with similar cryotherapy approaches, indicating potential for this novel device to enhance treatment outcomes.
Where this research is happening
AUSTIN, UNITED STATES
- NANOHMICS, INC. — AUSTIN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SAVOY, STEVE MICHAEL — NANOHMICS, INC.
- Study coordinator: SAVOY, STEVE MICHAEL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.